Study guide
8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)
NABP MPJE Multistate Pharmacy Jurisprudence Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pharmacist Licensure & Reciprocity
1.1 Initial Licensure Requirements & Examinations 1.2 License Renewal, Continuing Education (CE) & Status 1.3 Reciprocity, License Transfer & Multistate Licensure 1.4 Disciplinary Actions, Board Hearings, Sanctions & Reinstatement
2 Chapter 2: Pharmacy Personnel Roles & Supervision Ratios
2.1 Pharmacy Interns: Scope of Practice, Supervision & Preceptor Rules 2.2 Pharmacy Technicians: Registration, Certification & Permitted Duties 2.3 Technician-to-Pharmacist Ratios & Delegated Tasks 2.4 Non-Pharmacist Personnel & Automated Dispensing Technology Roles
3 Chapter 3: Prescriptive Authority & Practitioner Categories
3.1 Physicians, Dentists, Veterinarians & Podiatrists: Prescribing Scope 3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority 3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions 3.4 Self-Prescribing & Prescribing for Family Members
4 Chapter 4: Patient Counseling & Drug Utilization Review (OBRA '90)
4.1 OBRA '90 Mandates & Prospective Drug Utilization Review (DUR) 4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation 4.3 Patient Profile Requirements & Retrospective DUR
5 Chapter 5: Advanced Pharmacist Practice & Collaborative Agreements
5.1 Collaborative Practice Agreements (CPAs) & Protocol-Based Care 5.2 Pharmacist Immunization Authority & Vaccine Administration Protocols 5.3 Medication Therapy Management (MTM) & Point-of-Care Testing (POCT) 5.4 Hormonal Contraceptive, Naloxone & Post-Exposure Prophylaxis (PEP/PrEP) Prescribing
6 Chapter 6: Federal Controlled Substances Act (CSA) & Scheduling
6.1 Controlled Substance Schedules (CI through CV) & Classification Criteria 6.2 DEA Registration: Types, Forms (224, 225, 363) & Renewal Cycles 6.3 Scheduled Listed Chemical Products (SLCPs) & Combat Methamphetamine Epidemic Act (CMEA)
7 Chapter 7: Controlled Substance Prescriptions & Legitimate Purpose
7.1 Corresponding Responsibility & Red Flags for Improper Prescribing 7.2 Required Components of Controlled Substance Prescriptions 7.3 Electronic Prescriptions for Controlled Substances (EPCS) & Security Requirements 7.4 Emergency Schedule II Prescriptions & Partial Filling Rules (CARA Act)
8 Chapter 8: Controlled Substance Ordering, Inventory & Recordkeeping
8.1 Ordering Schedule II Substances: CSOS & DEA Form 222 Execution 8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness) 8.3 Theft, Significant Loss (DEA Form 106) & Disposal/Destruction (DEA Form 41) 8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)
9 Chapter 9: Federal Pure Food, Drug & Cosmetic Act (FD&C Act) & Drug Safety
9.1 Adulteration vs. Misbranding: Statutory Definitions & Legal Violations 9.2 Prescription Labeling Requirements, Expiration Dates & Side Effect Statements 9.3 Poison Prevention Packaging Act (PPPA) & Child-Resistant Container Exemptions 9.4 Drug Recalls (Class I, II, III) & Market Withdrawals 9.5 Drug Product Selection, Generic Substitution & DAW Codes 9.6 Returning & Reusing Dispensed Drugs: Restocking, Redispensing & Repository Programs
10 Chapter 10: Drug Supply Chain Security Act (DSCSA) & Commercial Distribution
10.1 DSCSA Track-and-Trace Requirements: Transaction Information & Statements 10.2 Suspect & Illegitimate Product Verification, Quarantine & Notification 10.3 Prescription Drug Marketing Act (PDMA): Samples, Reimportation & Wholesale Distribution
11 Chapter 11: Compounding Standards: USP <795>, <797> & <800>
11.1 Section 503A vs. 503B Compounding Facilities (DQSA Architecture) 11.2 Non-Sterile Compounding (USP <795>) & Beyond-Use Dating (BUD) 11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD 11.4 Hazardous Drug Handling (USP <800>): Engineering Controls & Personal Protective Equipment
12 Chapter 12: Pharmacy Operational Security, Records & Telepharmacy
12.1 Physical Pharmacy Security, Alarm Systems & Keyholder Rules 12.2 Mandatory Pharmacy Records Retention & Audit Inspection Readiness 12.3 Central Fill, Automated Dispensing Systems (ADS) & Telepharmacy Operations 12.4 HIPAA Privacy Rule, Patient Records & Breach Notification Protocols
8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)
Key Takeaways Explain This Topic AI
Under federal law, a paper or oral Schedule II prescription cannot be transferred between retail pharmacies; since August 28, 2023, an unfilled electronic Schedule II prescription may be transferred once for initial filling at the patient's request (21 CFR 1306.08(e)).
Schedule III, IV, and V prescriptions may be transferred on a one-time basis between independent pharmacies, or up to max authorized refills for shared real-time databases.
Transferring pharmacists must write 'VOID' on the prescription and document receiving pharmacy DEA and pharmacist details.
Prescription Drug Monitoring Programs (PDMPs) are state-run databases that track controlled substance dispensing to curb diversion and doctor shopping.
Under 21 CFR § 1306.04, pharmacists share a 'Corresponding Responsibility' with prescribers to ensure controlled substance prescriptions serve a legitimate medical purpose.
Last updated: November 2026
8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)
To prevent prescription forgery, duplicate dispensing, and diversion while supporting patient continuity of care, federal and state laws strictly govern the transfer of controlled substance prescriptions between pharmacies (21 CFR § 1306.25). Additionally, state-administered Prescription Drug Monitoring Programs (PDMPs) serve as essential electronic tools for evaluating patient prescription histories prior to dispensing.
Controlled Substance Prescription Transfer Rules
Federal regulation dictates transfer eligibility based on the controlled substance schedule and the pharmacy's IT architecture:
1. Schedule II Prescriptions (CII)
No refill transfers : Schedule II prescriptions cannot have refills, and a paper or oral Schedule II prescription cannot be transferred between retail pharmacies (only the EPCS exception below applies). Because Schedule II prescriptions cannot have refills, a patient who wants their CII filled at a different pharmacy must obtain a new written or electronic prescription from the practitioner.
EPCS Exception : Under a DEA rule update effective August 2023, an unfilled Electronic Prescription for Controlled Substances (EPCS) for Schedules II–V may be transferred electronically between pharmacies one time, provided strict software PKI interoperability standards are met.
2. Schedule III, IV, and V Prescriptions (CIII–CV)
One-Time Transfer Rule : Prescriptions for Schedule III, IV, and V controlled substances may be transferred between independent retail pharmacies on a one-time basis only for refill dispensing.
Real-Time Shared Database Exception : Pharmacies that share a real-time, online electronic database (e.g., corporate chain pharmacies sharing a unified dispensing system) are permitted to transfer CIII–CV prescriptions up to the maximum refills authorized by the prescriber.
- Controlled Substance Schedule Transfer Eligibility Maximum Transfer Frequency
- Schedule II (Paper / Standard) NOT Transferable N/A (Requires new prescription)
- Schedule II–V (Unfilled EPCS) Transferable electronically 1 time (Strict DEA EPCS software rule)
- Schedule III–V (Independent Pharmacies) Transferable for refills 1 time only
- Schedule III–V (Shared Database Chain) Transferable for refills Up to max authorized refills
- Mandatory Transfer Operational Procedures
When executing a legal transfer of a Schedule III–V prescription, both the transferring pharmacy and the receiving pharmacy must perform specific recordkeeping duties under 21 CFR § 1306.25:
Transferring Pharmacy (Outbound Duties):
Write the word "VOID" on the face of the invalidated paper prescription (or mark electronic record as transferred/invalidated).
Record on the reverse of the prescription or electronic file:
Name, address, and DEA registration number of the receiving pharmacy.
Name of the receiving pharmacist .
Date of transfer.
Name of the transferring pharmacist .
Receiving Pharmacy (Inbound Duties):
Write the word "TRANSFER" on the face of the paper prescription or electronic record.
Record all mandatory prescription details:
Original prescription issue date and original dispensing date.
Original number of authorized refills and number of valid refills remaining.
Date and location of last refill.
Prescription number from transferring pharmacy.
Name, address, and DEA registration number of transferring pharmacy.
Name of transferring pharmacist.
Retention : Both transferring and receiving records must be maintained for at least 2 years from the date of the last refill.
Prescription Drug Monitoring Programs (PDMPs)
A Prescription Drug Monitoring Program (PDMP) is a state-level electronic database that collects dedicated dispensing data for controlled substances (and drugs of concern such as gabapentin or pseudoephedrine) from retail pharmacies.
Objectives of PDMPs:
Identify instances of doctor shopping (patients obtaining controlled substance prescriptions from multiple prescribers).
Detect polypharmacy and dangerous multi-drug regimens (e.g., the "Holy Trinity": an opioid + benzodiazepine + muscle relaxant).
Assist prescribers and pharmacists in evaluating patient risk before prescribing or dispensing controlled drugs.
Mandatory PDMP Query Triggers:
State MPJE exams frequently test specific scenarios where a pharmacist is legally mandated to query the state PDMP prior to dispensing. Common statutory triggers include:
Initial dispensing of any Schedule II opioid or benzodiazepine.
Prescriptions originating from an out-of-state prescriber .
Cash payments for high-dose controlled substances.
Prescriptions exceeding specific Morphine Milligram Equivalent (MME) thresholds (e.g., >50 MME/day or >90 MME/day ).
Patients receiving controlled substances from 3 or more prescribers or pharmacies within a 90-day window.
Corresponding Responsibility & Red Flags
Under 21 CFR § 1306.04 , a prescription for a controlled substance must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice. The law establishes the doctrine of Corresponding Responsibility :
While the primary responsibility rests with the prescribing practitioner, a corresponding responsibility rests with the pharmacist who fills the prescription.
An order purporting to be a prescription that is not issued in the usual course of professional treatment is an invalid prescription . A pharmacist who knowingly fills an invalid prescription is subject to criminal prosecution, civil penalties, and license revocation.
Red Flags Requiring Investigation & PDMP Verification:
Pattern Prescribing : Prescriber issuing identical drug cocktails (e.g., Oxycodone 30 mg + Alprazolam 2 mg + Carisoprodol 350 mg) to numerous patients.
Geographic Anomaly : Patient traveling long distances (e.g., across state lines) to see a prescriber or fill a prescription.
Early Refills : Persistent requests for early refills based on lost or stolen medication claims.
Cash Payments : Patient insisting on paying cash despite having active prescription insurance coverage.
Lack of Diagnostic Fit : Doses prescribed significantly exceed recognized clinical guidelines without documented pain management rationale.